TY - JOUR
T1 - Uptake, barriers and correlates of influenza vaccination among people who inject drugs in Australia
AU - Price, Olivia
AU - Dietze, Paul
AU - Sullivan, Sheena G.
AU - Salom, Caroline
AU - Peacock, Amy
N1 - Funding Information:
Drug Trends (including the IDRS) and the National Drug and Alcohol Research Centre are funded by the Australian Government Department of Health under the Drug and Alcohol Program. The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. AP is supported by an NHMRC Investigator Fellowship (#1174630). PD is funded by an NHRMC Senior Research Fellowship (#1136090).AP has received untied educational grant from Seqirus and Mundipharma for study of opioid medications. PD has received untied educational grant from Gilead sciences for work related to hepatitis C and an untied educational grant from Indivior. PD has served as an unpaid member of an Advisory Board for Mundipharma. All other authors have no conflicts of interest to declare.
Funding Information:
Drug Trends (including the IDRS) and the National Drug and Alcohol Research Centre are funded by the Australian Government Department of Health under the Drug and Alcohol Program. The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. AP is supported by an NHMRC Investigator Fellowship ( #1174630 ). PD is funded by an NHRMC Senior Research Fellowship ( #1136090 ).
Publisher Copyright:
© 2021
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Background: Comorbid chronic health conditions place people who inject drugs (PWID) at risk of severe health outcomes after influenza infection. However, little is known about the uptake, barriers and correlates of influenza vaccination among PWID. Methods: During structured surveys, 872 PWID reported whether they had received an influenza vaccination during the last year (disaggregated as pre- or post-March 2020 to ascertain current season vaccine uptake), and if not, the barriers to vaccination. Logistic regression was used to examine demographic, drug use, health and service engagement correlates of vaccine uptake. Results: Thirty-nine percent of participants reported past-year influenza vaccination, with one-quarter (24 %) vaccinated in the current season. The main barriers to vaccination were motivation-based, with few citing issues relating to affordability, supply or perceived stigma. Opioid agonist therapy in the past six months was significantly associated with vaccination. Conclusions: Influenza vaccine uptake was lower among PWID than the Australian general population. Provision of the vaccine at services commonly accessed by PWID may increase uptake.
AB - Background: Comorbid chronic health conditions place people who inject drugs (PWID) at risk of severe health outcomes after influenza infection. However, little is known about the uptake, barriers and correlates of influenza vaccination among PWID. Methods: During structured surveys, 872 PWID reported whether they had received an influenza vaccination during the last year (disaggregated as pre- or post-March 2020 to ascertain current season vaccine uptake), and if not, the barriers to vaccination. Logistic regression was used to examine demographic, drug use, health and service engagement correlates of vaccine uptake. Results: Thirty-nine percent of participants reported past-year influenza vaccination, with one-quarter (24 %) vaccinated in the current season. The main barriers to vaccination were motivation-based, with few citing issues relating to affordability, supply or perceived stigma. Opioid agonist therapy in the past six months was significantly associated with vaccination. Conclusions: Influenza vaccine uptake was lower among PWID than the Australian general population. Provision of the vaccine at services commonly accessed by PWID may increase uptake.
KW - Influenza vaccine
KW - People who inject drugs
KW - Vaccination barriers
KW - Vaccine hesitancy
UR - http://www.scopus.com/inward/record.url?scp=85109116842&partnerID=8YFLogxK
U2 - 10.1016/j.drugalcdep.2021.108882
DO - 10.1016/j.drugalcdep.2021.108882
M3 - Article
C2 - 34216866
AN - SCOPUS:85109116842
SN - 0376-8716
VL - 226
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
M1 - 108882
ER -
